Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) reached a new 52-week low during trading on Monday . The stock traded as low as $4.70 and last traded at $4.89, with a volume of 308409 shares changing hands. The stock had previously closed at $4.49.
Evotec Stock Up 8.9 %
The business’s fifty day moving average price is $4.19 and its two-hundred day moving average price is $4.33. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The firm has a market capitalization of $1.61 billion, a P/E ratio of 56.00 and a beta of 0.98.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Further Reading
- Five stocks we like better than Evotec
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Are Dividend Challengers?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
